J Kellogg Parsons

Summary

Affiliation: Johns Hopkins University
Country: USA

Publications

  1. ncbi request reprint The historical origins of interstitial cystitis
    J Kellogg Parsons
    Brady Urological Institute, Johns Hopkins Medical Institutions, Baltimore, Maryland 21287, USA
    J Urol 171:20-2. 2004
  2. ncbi request reprint Complexed prostate specific antigen (PSA) reduces unnecessary prostate biopsies in the 2.6-4.0 ng/mL range of total PSA
    J Kellogg Parsons
    The James Buchanan Brady Urological Institute, The Johns Hopkins Medical Institutions Baltimore, MD 21287, USA
    BJU Int 94:47-50. 2004
  3. ncbi request reprint Serum testosterone and the risk of prostate cancer: potential implications for testosterone therapy
    J Kellogg Parsons
    The James Buchanan Brady Urological Institute, The Johns Hopkins Hospital, Baltimore, MD 21287, USA
    Cancer Epidemiol Biomarkers Prev 14:2257-60. 2005
  4. ncbi request reprint Complexed prostate-specific antigen for the diagnosis of biochemical recurrence after radical prostatectomy
    J Kellogg Parsons
    James Buchanan Brady Urological Institute, The Johns Hopkins Medical Institution, Baltimore, MD, USA
    BJU Int 99:758-61. 2007
  5. ncbi request reprint Can a baseline prostate specific antigen level identify men who will have lower urinary tract symptoms later in life?
    H Ballentine Carter
    Department of Urology, The Johns Hopkins University School of Medicine, Baltimore, Maryland, USA
    J Urol 173:2040-3. 2005
  6. ncbi request reprint Clinical interpretation of prostate biopsy reports
    J Kellogg Parsons
    James Buchanan Brady Urological Institute, Johns Hopkins Medical Institutions, Baltimore, Maryland, USA
    Urology 67:452-7. 2006
  7. doi request reprint Monocyte chemotactic protein-1 (MCP-1/CCL2) is associated with prostatic growth dysregulation and benign prostatic hyperplasia
    Kazutoshi Fujita
    The Brady Urological Institute, Johns Hopkins Medical Institutions, Baltimore, Maryland 21218, USA
    Prostate 70:473-81. 2010
  8. ncbi request reprint Applying complexed prostate-specific antigen to clinical practice
    J Kellogg Parsons
    James Buchanan Brady Urological Institute, Johns Hopkins Medical Institutions, Baltimore, Maryland 21287, USA
    Urology 63:815-8. 2004
  9. ncbi request reprint Multidisciplinary, inpatient directly observed therapy for HIV-1-infected children and adolescents failing HAART: A retrospective study
    Genevieve N Parsons
    Division of General Pediatrics and Adolescent Medicine, Johns Hopkins Medical Institutions, Baltimore, Maryland, USA
    AIDS Patient Care STDS 20:275-84. 2006
  10. ncbi request reprint Effect of methylprednisolone on return of sexual function after nerve-sparing radical retropubic prostatectomy
    J Kellogg Parsons
    James Buchanan Brady Urological Institute, Johns Hopkins Medical Institutions, Baltimore, Maryland 21287, USA
    Urology 64:987-90. 2004

Detail Information

Publications24

  1. ncbi request reprint The historical origins of interstitial cystitis
    J Kellogg Parsons
    Brady Urological Institute, Johns Hopkins Medical Institutions, Baltimore, Maryland 21287, USA
    J Urol 171:20-2. 2004
    ..We identify early descriptions of interstitial cystitis and trace its evolution as a clinical entity during the 19th century...
  2. ncbi request reprint Complexed prostate specific antigen (PSA) reduces unnecessary prostate biopsies in the 2.6-4.0 ng/mL range of total PSA
    J Kellogg Parsons
    The James Buchanan Brady Urological Institute, The Johns Hopkins Medical Institutions Baltimore, MD 21287, USA
    BJU Int 94:47-50. 2004
    ..To compare the performance of complexed prostate-specific antigen (cPSA) to total PSA (tPSA) and percentage free PSA (f/tPSA) in the diagnosis of prostate cancer for the tPSA range 2.6-4.0 ng/mL...
  3. ncbi request reprint Serum testosterone and the risk of prostate cancer: potential implications for testosterone therapy
    J Kellogg Parsons
    The James Buchanan Brady Urological Institute, The Johns Hopkins Hospital, Baltimore, MD 21287, USA
    Cancer Epidemiol Biomarkers Prev 14:2257-60. 2005
    ..We prospectively evaluated serum androgen concentrations and prostate cancer risk...
  4. ncbi request reprint Complexed prostate-specific antigen for the diagnosis of biochemical recurrence after radical prostatectomy
    J Kellogg Parsons
    James Buchanan Brady Urological Institute, The Johns Hopkins Medical Institution, Baltimore, MD, USA
    BJU Int 99:758-61. 2007
    ..To determine the validity of using complexed prostate-specific antigen (cPSA) levels for diagnosing biochemical recurrence after radical prostatectomy (RP)...
  5. ncbi request reprint Can a baseline prostate specific antigen level identify men who will have lower urinary tract symptoms later in life?
    H Ballentine Carter
    Department of Urology, The Johns Hopkins University School of Medicine, Baltimore, Maryland, USA
    J Urol 173:2040-3. 2005
    ..We evaluated the relationship between baseline prostate specific antigen (PSA) and subsequent lower urinary tract symptom development during 3 decades in unselected men in the Baltimore Longitudinal Study of Aging...
  6. ncbi request reprint Clinical interpretation of prostate biopsy reports
    J Kellogg Parsons
    James Buchanan Brady Urological Institute, Johns Hopkins Medical Institutions, Baltimore, Maryland, USA
    Urology 67:452-7. 2006
  7. doi request reprint Monocyte chemotactic protein-1 (MCP-1/CCL2) is associated with prostatic growth dysregulation and benign prostatic hyperplasia
    Kazutoshi Fujita
    The Brady Urological Institute, Johns Hopkins Medical Institutions, Baltimore, Maryland 21218, USA
    Prostate 70:473-81. 2010
    ..Cytokines are not only key mediators of inflammation but may also play important roles in the initiation and progression of BPH...
  8. ncbi request reprint Applying complexed prostate-specific antigen to clinical practice
    J Kellogg Parsons
    James Buchanan Brady Urological Institute, Johns Hopkins Medical Institutions, Baltimore, Maryland 21287, USA
    Urology 63:815-8. 2004
  9. ncbi request reprint Multidisciplinary, inpatient directly observed therapy for HIV-1-infected children and adolescents failing HAART: A retrospective study
    Genevieve N Parsons
    Division of General Pediatrics and Adolescent Medicine, Johns Hopkins Medical Institutions, Baltimore, Maryland, USA
    AIDS Patient Care STDS 20:275-84. 2006
    ....
  10. ncbi request reprint Effect of methylprednisolone on return of sexual function after nerve-sparing radical retropubic prostatectomy
    J Kellogg Parsons
    James Buchanan Brady Urological Institute, Johns Hopkins Medical Institutions, Baltimore, Maryland 21287, USA
    Urology 64:987-90. 2004
    ..To determine whether postoperative methylprednisolone improves the recovery of sexual function after nerve-sparing radical retropubic prostatectomy...
  11. ncbi request reprint Extraction of UroLume endoprostheses with one-stage urethral reconstruction
    J Kellogg Parsons
    James Buchanan Brady Urological Institute, Johns Hopkins Medical Institutions, Baltimore, Maryland 21287, USA
    Urology 64:582-4. 2004
    ..We have used this technique in 3 patients with occluded urethral stents placed for bulbar stricture disease. All patients experienced acceptable outcomes...
  12. ncbi request reprint Complications of abdominal urologic laparoscopy: longitudinal five-year analysis
    J Kellogg Parsons
    James Buchanan Brady Urological Institute, Johns Hopkins Medical Institutions, Baltimore, Maryland, USA
    Urology 63:27-32. 2004
    ..To analyze complications of abdominal laparoscopic surgery of the urinary tract at a single institution during a 5-year period...
  13. ncbi request reprint Vaginal reconstruction utilizing sigmoid colon: Complications and long-term results
    J Kellogg Parsons
    Division of Pediatric Urology, The James Buchanan Brady Urological Institute, Department of Surgery, The Johns Hopkins Hospital, The Johns Hopkins University School of Medicine, Baltimore, MD, USA
    J Pediatr Surg 37:629-33. 2002
    ..The purpose of this study was to evaluate complication rates and long-term patient outcomes in the use of sigmoid segments in vaginal reconstruction for congenital anomalies...
  14. pmc Metabolic factors associated with benign prostatic hyperplasia
    J Kellogg Parsons
    Division of Urology, University of California San Diego, 200 West Arbor Drive, San Diego, California 21287, USA
    J Clin Endocrinol Metab 91:2562-8. 2006
    ..Obesity and associated abnormalities in glucose homeostasis may play a role in benign prostatic hyperplasia development by influencing prostate growth...
  15. doi request reprint The Men's Eating and Living (MEAL) study: a Cancer and Leukemia Group B pilot trial of dietary intervention for the treatment of prostate cancer
    J Kellogg Parsons
    Moores Cancer Center, University of California San Diego, La Jolla, California, USA
    Urology 72:633-7. 2008
    ..To evaluate the feasibility of implementing a diet-based intervention in men with prostate cancer...
  16. ncbi request reprint Commentary on BPH and public health--have we lost the forest through the trees?
    J Kellogg Parsons
    J Urol 179:S81. 2008
  17. doi request reprint Physical activity, benign prostatic hyperplasia, and lower urinary tract symptoms
    J Kellogg Parsons
    Division of Urology, Department of Surgery, University of California, San Diego School of Medicine, La Jolla, CA 92103 8897, USA
    Eur Urol 53:1228-35. 2008
    ..While some studies have indicated that physical activity may protect against benign prostatic hyperplasia (BPH) and lower urinary tract symptoms (LUTS), others have not...
  18. doi request reprint Outcomes of retropubic, laparoscopic, and robotic-assisted prostatectomy
    J Kellogg Parsons
    Division of Urology, University of California San Diego School of Medicine, San Diego, California 21287, USA
    Urology 72:412-6. 2008
    ..To compare outcomes of radical retropubic, laparoscopic, and robotic-assisted prostatectomy using evidence-based analysis...
  19. doi request reprint Dietary modification in patients with prostate cancer on active surveillance: a randomized, multicentre feasibility study
    J Kellogg Parsons
    Moores Comprehensive Cancer Center, University of California San Diego, La Jolla, CA 21287, USA
    BJU Int 101:1227-31. 2008
    ..To evaluate the feasibility of implementing a diet-based intervention in men with prostate cancer on active surveillance, as changes in diet might potentially inhibit the progression of prostate cancer...
  20. pmc Lipids, lipoproteins and the risk of benign prostatic hyperplasia in community-dwelling men
    J Kellogg Parsons
    Division of Urology, Department of Surgery, University of California San Diego School of Medicine, La Jolla, CA 21287, USA
    BJU Int 101:313-8. 2008
    ..To examine the associations of serum lipids and lipoproteins with benign prostatic hyperplasia (BPH) in community-dwelling men...
  21. ncbi request reprint Modifiable risk factors for benign prostatic hyperplasia and lower urinary tract symptoms: new approaches to old problems
    J Kellogg Parsons
    Division of Urology, University of California San Diego School of Medicine, San Diego, California 92103 8897, USA
    J Urol 178:395-401. 2007
    ..Benign prostatic hyperplasia is generally not regarded as a preventable disease. However, accumulating evidence suggests that modifiable factors may influence the risk of benign prostatic hyperplasia and lower urinary tract symptoms...
  22. ncbi request reprint Epidemiologic issues in interstitial cystitis
    J Kellogg Parsons
    Division of Urology, Department of Surgery, University of California San Diego Medical Center, University of California, San Diego, San Diego, California 92103 8897, USA
    Urology 69:5-8. 2007
    ..Because IC is substantially underdiagnosed, its actual prevalence may be much higher. Indeed, the disease may affect as many as 1 in 4 to 5 women and 1 in 20 men...
  23. ncbi request reprint Local anesthetic reduces pain associated with transrectal ultrasound-guided prostate biopsy: a meta-analysis
    Lori Hergan
    Division of Urology, University of California, San Diego, School of Medicine, San Diego, California 92103 8897, USA
    Urology 69:520-5. 2007
    ..To determine whether local anesthetic decreases the pain associated with transrectal ultrasound-guided prostate needle biopsy...
  24. ncbi request reprint Hugh Hampton Young, benign prostatic hyperplasia, and "the cure of prostatic obstruction"
    J Kellogg Parsons
    J Am Coll Surg 201:654-5. 2005